Have your own idea? Try our Stock Screener
Argentinian (MERVAL) Pharma Industry Analysis
UpdatedDec 26, 2024
DataAggregated Company Financials
Companies2
- 7D5.0%
- 3M93.3%
- 1Y152.3%
- YTDn/a
Over the last 7 days, the Pharma industry has remained flat, although notably Laboratorios RichmondC.I.F gained 5.3%. As for the the longer term, the industry is up 146% over the past 12 months.
Industry Valuation and Performance
Has the Argentinian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 26 Dec 2024 | AR$149.5b | AR$42.6b | AR$18.2b | 6.7x | 8.2x | 3.5x |
| Sat, 23 Nov 2024 | AR$153.1b | AR$42.6b | AR$18.2b | 6.9x | 8.4x | 3.6x |
| Mon, 21 Oct 2024 | AR$81.4b | AR$40.7b | AR$4.6b | 12.8x | 17.9x | 2x |
| Wed, 18 Sep 2024 | AR$76.8b | AR$40.7b | AR$4.6b | 12.8x | 16.9x | 1.9x |
| Fri, 16 Aug 2024 | AR$83.9b | AR$41.1b | -AR$3,264,658,797.00 | 3.6x | -25.7x | 2x |
| Sun, 14 Jul 2024 | AR$84.6b | AR$41.1b | -AR$3,264,658,797.00 | 4.6x | -25.9x | 2.1x |
| Tue, 11 Jun 2024 | AR$84.7b | AR$41.1b | -AR$3,264,658,797.00 | 4.5x | -25.9x | 2.1x |
| Thu, 09 May 2024 | AR$78.8b | AR$43.6b | -AR$10,287,966,966.00 | 8.7x | -7.7x | 1.8x |
| Sat, 06 Apr 2024 | AR$73.3b | AR$9.6b | -AR$4,702,241,388.00 | 58.1x | -15.6x | 7.6x |
| Mon, 04 Mar 2024 | AR$69.4b | AR$9.6b | -AR$4,702,241,388.00 | 54.9x | -14.8x | 7.2x |
| Wed, 31 Jan 2024 | AR$85.7b | AR$10.3b | -AR$4,704,193,685.00 | 59.4x | -18.2x | 8.3x |
| Fri, 29 Dec 2023 | AR$59.6b | AR$10.3b | -AR$4,704,193,685.00 | 34.7x | -12.7x | 5.8x |
| Sun, 26 Nov 2023 | AR$63.4b | AR$19.4b | -AR$4,675,725,481.00 | n/a | -13.6x | 3.3x |
| Tue, 24 Oct 2023 | AR$55.8b | AR$13.0b | -AR$2,496,856,221.00 | n/a | -22.3x | 4.3x |
| Thu, 21 Sep 2023 | AR$45.5b | AR$13.0b | -AR$2,496,856,221.00 | n/a | -18.2x | 3.5x |
| Sat, 19 Aug 2023 | AR$49.9b | AR$18.8b | -AR$150,001,147.00 | 15.4x | -333x | 2.7x |
| Mon, 17 Jul 2023 | AR$45.3b | AR$18.8b | -AR$150,001,147.00 | 13.2x | -302.2x | 2.4x |
| Wed, 14 Jun 2023 | AR$42.3b | AR$19.1b | AR$209.1m | 136.2x | 202.5x | 2.2x |
| Fri, 12 May 2023 | AR$33.7b | AR$19.1b | AR$209.1m | 108.2x | 161.4x | 1.8x |
| Sun, 09 Apr 2023 | AR$32.1b | AR$19.1b | AR$209.1m | 102.8x | 153.4x | 1.7x |
| Tue, 07 Mar 2023 | AR$32.4b | AR$13.7b | AR$1.5b | 17.4x | 21x | 2.4x |
| Thu, 02 Feb 2023 | AR$33.4b | AR$13.7b | AR$1.5b | 17.5x | 21.6x | 2.4x |
| Sat, 31 Dec 2022 | AR$32.0b | AR$13.8b | AR$1.5b | 20.9x | 21.3x | 2.3x |
| Mon, 28 Nov 2022 | AR$27.3b | AR$19.6b | AR$1.4b | 19.7x | 20x | 1.4x |
| Wed, 26 Oct 2022 | AR$29.0b | AR$19.7b | AR$1.4b | 23.7x | 21x | 1.5x |
| Fri, 23 Sep 2022 | AR$25.2b | AR$19.7b | AR$1.4b | 24.4x | 18.2x | 1.3x |
| Sun, 21 Aug 2022 | AR$22.4b | AR$17.8b | AR$987.0m | 25.7x | 22.7x | 1.3x |
| Tue, 19 Jul 2022 | AR$21.0b | AR$17.6b | AR$940.9m | 21.2x | 22.3x | 1.2x |
| Thu, 16 Jun 2022 | AR$20.0b | AR$9.9b | AR$101.3m | 150.6x | 197.1x | 2x |
| Sat, 14 May 2022 | AR$19.6b | AR$9.9b | AR$101.3m | 147.5x | 193.7x | 2x |
| Mon, 11 Apr 2022 | AR$19.8b | AR$9.9b | AR$101.3m | 149.8x | 195.9x | 2x |
| Wed, 09 Mar 2022 | AR$20.5b | AR$9.9b | AR$101.3m | 154.4x | 202.2x | 2.1x |
| Fri, 04 Feb 2022 | AR$20.7b | AR$9.9b | AR$101.3m | 154.7x | 204.3x | 2.1x |
| Sun, 02 Jan 2022 | AR$18.4b | AR$9.9b | AR$101.3m | 138.2x | 181.6x | 1.9x |
Price to Earnings Ratio
181.6x
Current Industry PE
- There are only 2 companies in the Argentinean Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 464% per year over the last three years.
- Revenues for these companies have grown 62% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Argentinian Pharma compare with similar industries?
| AR Market | 5.93% | |
| Healthcare | 4.98% | |
| Pharma | 4.98% | |
| Pharma | 4.98% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| RICH Laboratorios RichmondC.I.F | AR$1.79k | 5.3% +AR$7.3b | 156.1% | PE8.4x |